Cargando…

sup 8 sup 9 Sr and sup 1 sup 5 sup 3 Sm-EDTMP therapy of disseminated skeletal metastasis

A retrospective analysis was performed on 72 patients with disseminated skeletal metastasis to evaluate the effect of strontium-89 or samarium-153 EDTMP therapy. There existed 87.88% of clinical response, 12.12% of no response in the group treated with strontium-89 as compared with 90.24% of clinica...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang Jun Ning, Hong Cheng Jiao, Zhu Shou Peng
Lenguaje:chi
Publicado: 2001
Materias:
Acceso en línea:http://cds.cern.ch/record/748221
_version_ 1780904232087453696
author Zhang Jun Ning
Hong Cheng Jiao
Zhu Shou Peng
author_facet Zhang Jun Ning
Hong Cheng Jiao
Zhu Shou Peng
author_sort Zhang Jun Ning
collection CERN
description A retrospective analysis was performed on 72 patients with disseminated skeletal metastasis to evaluate the effect of strontium-89 or samarium-153 EDTMP therapy. There existed 87.88% of clinical response, 12.12% of no response in the group treated with strontium-89 as compared with 90.24% of clinical response, 9.76% no response in one treated with samarium-153 EDTMP; and there were no correlation between the treatment results and the amounts of isotopes administrated. The results suggest that strontium-89 or samarium-153 EDTMP therapy is a method of first choice in the palliative treatment for disseminated skeletal metastasis
id cern-748221
institution Organización Europea para la Investigación Nuclear
language chi
publishDate 2001
record_format invenio
spelling cern-7482212019-09-30T06:29:59Zhttp://cds.cern.ch/record/748221chiZhang Jun NingHong Cheng JiaoZhu Shou Pengsup 8 sup 9 Sr and sup 1 sup 5 sup 3 Sm-EDTMP therapy of disseminated skeletal metastasisHealth Physics and Radiation EffectsA retrospective analysis was performed on 72 patients with disseminated skeletal metastasis to evaluate the effect of strontium-89 or samarium-153 EDTMP therapy. There existed 87.88% of clinical response, 12.12% of no response in the group treated with strontium-89 as compared with 90.24% of clinical response, 9.76% no response in one treated with samarium-153 EDTMP; and there were no correlation between the treatment results and the amounts of isotopes administrated. The results suggest that strontium-89 or samarium-153 EDTMP therapy is a method of first choice in the palliative treatment for disseminated skeletal metastasisCNIC-01606SZU-0004oai:cds.cern.ch:7482212001
spellingShingle Health Physics and Radiation Effects
Zhang Jun Ning
Hong Cheng Jiao
Zhu Shou Peng
sup 8 sup 9 Sr and sup 1 sup 5 sup 3 Sm-EDTMP therapy of disseminated skeletal metastasis
title sup 8 sup 9 Sr and sup 1 sup 5 sup 3 Sm-EDTMP therapy of disseminated skeletal metastasis
title_full sup 8 sup 9 Sr and sup 1 sup 5 sup 3 Sm-EDTMP therapy of disseminated skeletal metastasis
title_fullStr sup 8 sup 9 Sr and sup 1 sup 5 sup 3 Sm-EDTMP therapy of disseminated skeletal metastasis
title_full_unstemmed sup 8 sup 9 Sr and sup 1 sup 5 sup 3 Sm-EDTMP therapy of disseminated skeletal metastasis
title_short sup 8 sup 9 Sr and sup 1 sup 5 sup 3 Sm-EDTMP therapy of disseminated skeletal metastasis
title_sort sup 8 sup 9 sr and sup 1 sup 5 sup 3 sm-edtmp therapy of disseminated skeletal metastasis
topic Health Physics and Radiation Effects
url http://cds.cern.ch/record/748221
work_keys_str_mv AT zhangjunning sup8sup9srandsup1sup5sup3smedtmptherapyofdisseminatedskeletalmetastasis
AT hongchengjiao sup8sup9srandsup1sup5sup3smedtmptherapyofdisseminatedskeletalmetastasis
AT zhushoupeng sup8sup9srandsup1sup5sup3smedtmptherapyofdisseminatedskeletalmetastasis